“With the Magseed we have a good tool that is detectable, and shows no migration — and for that reason I think we will have good results in the MELODY Study” @ProfMarcThill explains why he's excited to see the results from the Magseed arm of the @EUBREAST #MELODY study. Find out more about the MELODY study 👇 endomag.com/en-gb/blog/produ…

We were on the lookout for a great poster at #SABCS23, then three came along at once! Yesterday, we saw these posters from @Dr_RachelFoster, Prof. Dr. med. Hans-Christian Kolberg and Dr. Eva Vikhe Patil: ▶️ The iBRA-NET localisation study comparing Magseed with the guidewire and RFID technology. ▶️ The AXSANA group sub-analysis of Magseed performance in target lymph nodes. ▶️ The SentiRecur feasibility study which analysed Magtrace effectiveness in patients with breast cancer recurrence. We'll be keeping an eye out over the next few days for even more exciting new data! 👀

Magtrace has been officially recommended for use in SLNB by the MTP Council! The Swedish-based group acknowledged the advantages of switching to Magtrace, in particular eliminating the reliance on nuclear medicine and logistical advantages. Read more here👇

Don't just believe the hype, see it for yourself. Watch all of the highlights from the inaugural Transatlantic Breast Cancer Collaborative meeting - with Season 1 now available on-demand. #TBCCOnDemand

🇺🇸 🇬🇧 🇩🇪🇨🇦 🇸🇪 🇦🇺 🇿🇦 Bringing together the best, from both sides of the Atlantic. Now you can watch the debates, didactics, and discussions from the industry's first "anti-meeting" meeting - the Transatlantic Breast Cancer Collaborative (TBCC). #TBCCOnDemand Watch now 👇

Seed Localisation + SLNB in one platform. Backed by data and trusted by surgeons. That's why it's the UK's #1 Tissue localisation platform. #ABSConference2023 #MagTeam #ATNEC

360 detection matters when it comes to localization. Great poster from @1LondonBreast, @mikeboland86 and Mr Dan Leff from @ImperialNHS #ASBrS23

Have you made your #SaveOurNodes pledge yet? So far we've had 53 physicians commit to reducing unnecessary axillary surgery for their patients by finding out more about delayed SLNB. Join them by visiting our booth at #ASBrS23 - you won’t be able to miss us!

We're showcasing our most advanced surgical guidance system yet... Come and take a look at the #NewSentimag down in the exhibitor hall at #ASBrS23

See you soon at #ASBrS23! – at Boston, MA

Excellent debate on TAD at #MBCC2023 @KellyKhunt discussing how @MDAndersonNews place #Magseed in nodes for TAD #breastcancer

Removing the lesion and performing the SLNB with just one localization platform – it’s a no-brainer. Watch @e_pantiora of @UU_University explain how the MagTotal approach delivers precision localization accuracy, reduces operating time and is easy to implement. 👇

"News that will completely change the way breast cancer is staged across the U.S." Read how the recent FDA approval of Magtrace for all breast cancer procedures will play a major role in reducing reliance on radioisotopes. More from @biospace 👇